NO331464B1 - Antistoff for immunoanalyse for neonicotinyl-insekticider, proteinkonjugat, fremgangsmate for bestemmelse av konsentrasjon, samt et sett. - Google Patents
Antistoff for immunoanalyse for neonicotinyl-insekticider, proteinkonjugat, fremgangsmate for bestemmelse av konsentrasjon, samt et sett. Download PDFInfo
- Publication number
- NO331464B1 NO331464B1 NO20022684A NO20022684A NO331464B1 NO 331464 B1 NO331464 B1 NO 331464B1 NO 20022684 A NO20022684 A NO 20022684A NO 20022684 A NO20022684 A NO 20022684A NO 331464 B1 NO331464 B1 NO 331464B1
- Authority
- NO
- Norway
- Prior art keywords
- antibody
- neonicotinoid
- sample
- hapten
- insecticide
- Prior art date
Links
- 239000002917 insecticide Substances 0.000 title claims abstract description 88
- 238000000034 method Methods 0.000 title claims abstract description 59
- 238000003018 immunoassay Methods 0.000 title claims abstract description 51
- 102000004169 proteins and genes Human genes 0.000 title claims description 23
- 108090000623 proteins and genes Proteins 0.000 title claims description 23
- 239000000463 material Substances 0.000 claims abstract description 21
- 102000004190 Enzymes Human genes 0.000 claims description 33
- 108090000790 Enzymes Proteins 0.000 claims description 33
- 150000001875 compounds Chemical class 0.000 claims description 32
- -1 2-chloropyrid-5-yl Chemical group 0.000 claims description 28
- 239000007790 solid phase Substances 0.000 claims description 28
- 230000002163 immunogen Effects 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 23
- 239000005941 Thiamethoxam Substances 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 241001465754 Metazoa Species 0.000 claims description 15
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 14
- 230000003053 immunization Effects 0.000 claims description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 13
- 102000014914 Carrier Proteins Human genes 0.000 claims description 13
- 108010078791 Carrier Proteins Proteins 0.000 claims description 13
- 229940098773 bovine serum albumin Drugs 0.000 claims description 13
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 claims description 11
- 238000002649 immunization Methods 0.000 claims description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 11
- QMEQBOSUJUOXMX-UHFFFAOYSA-N 2h-oxadiazine Chemical group N1OC=CC=N1 QMEQBOSUJUOXMX-UHFFFAOYSA-N 0.000 claims description 10
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 claims description 9
- 239000005940 Thiacloprid Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 claims description 8
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 229940079888 nitenpyram Drugs 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 claims description 7
- 239000005875 Acetamiprid Substances 0.000 claims description 7
- 239000003593 chromogenic compound Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229960001005 tuberculin Drugs 0.000 claims description 7
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 6
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 6
- 240000000385 Brassica napus var. napus Species 0.000 claims description 6
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 6
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 6
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 6
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 6
- 239000005906 Imidacloprid Substances 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 6
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims description 6
- 229940056881 imidacloprid Drugs 0.000 claims description 6
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 claims description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 5
- 108010058846 Ovalbumin Proteins 0.000 claims description 5
- 229940092253 ovalbumin Drugs 0.000 claims description 5
- 241001269524 Dura Species 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 241000482268 Zea mays subsp. mays Species 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 241000219146 Gossypium Species 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000003976 plant breeding Methods 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 7
- 230000001902 propagating effect Effects 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 38
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000000575 pesticide Substances 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000427 antigen Substances 0.000 description 16
- 102000036639 antigens Human genes 0.000 description 16
- 108091007433 antigens Proteins 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000007795 chemical reaction product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000009260 cross reactivity Effects 0.000 description 3
- 230000001934 delay Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 240000004460 Tanacetum coccineum Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 210000000628 antibody-producing cell Anatomy 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- MZZBPDKVEFVLFF-UHFFFAOYSA-N cyanazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)(C)C#N)=N1 MZZBPDKVEFVLFF-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002728 pyrethroid Chemical class 0.000 description 2
- 229940015367 pyrethrum Drugs 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- WPGPRLVPWACBHW-UHFFFAOYSA-N (4-methoxy-4-oxobutyl)azanium;chloride Chemical compound Cl.COC(=O)CCCN WPGPRLVPWACBHW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- UFULAYFCSOUIOV-XSCORUHJSA-N 2-aminoethanethiol Chemical class NCC[35SH] UFULAYFCSOUIOV-XSCORUHJSA-N 0.000 description 1
- HKVYINROOPCUIP-UHFFFAOYSA-N 2-chloro-4-(chloromethyl)-1,3-thiazole Chemical compound ClCC1=CSC(Cl)=N1 HKVYINROOPCUIP-UHFFFAOYSA-N 0.000 description 1
- LDIYESWAILOJFP-UHFFFAOYSA-N 2h-oxadiazin-4-amine Chemical compound NC1=NNOC=C1 LDIYESWAILOJFP-UHFFFAOYSA-N 0.000 description 1
- SADHVOSOZBAAGL-UHFFFAOYSA-N 3-(trifluoromethoxy)aniline Chemical compound NC1=CC=CC(OC(F)(F)F)=C1 SADHVOSOZBAAGL-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- NXYLTUWDTBZQGX-UHFFFAOYSA-N ctk8h6630 Chemical compound C1=CC=C2C=C3C(N=C4C=CC=5C(C4=N4)=CC6=CC=CC=C6C=5)=C4C=CC3=CC2=C1 NXYLTUWDTBZQGX-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- BACHBFVBHLGWSL-UHFFFAOYSA-N methyl 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate Chemical group C1=CC(OC(C)C(=O)OC)=CC=C1OC1=CC=C(Cl)C=C1Cl BACHBFVBHLGWSL-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- GLIKYKRDYKKEBJ-UHFFFAOYSA-N methyl n'-nitrocarbamimidate Chemical compound CO\C(N)=N/[N+]([O-])=O GLIKYKRDYKKEBJ-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BACHBFVBHLGWSL-JTQLQIEISA-N rac-diclofop methyl Natural products C1=CC(O[C@@H](C)C(=O)OC)=CC=C1OC1=CC=C(Cl)C=C1Cl BACHBFVBHLGWSL-JTQLQIEISA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- IROINLKCQGIITA-UHFFFAOYSA-N terbutryn Chemical compound CCNC1=NC(NC(C)(C)C)=NC(SC)=N1 IROINLKCQGIITA-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XOPFESVZMSQIKC-UHFFFAOYSA-N triasulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)OCCCl)=N1 XOPFESVZMSQIKC-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Enzymes And Modification Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45678299A | 1999-12-08 | 1999-12-08 | |
| PCT/EP2000/012310 WO2001042787A2 (fr) | 1999-12-08 | 2000-12-06 | Dosage immunologique pour insecticides neonicotiniques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022684D0 NO20022684D0 (no) | 2002-06-06 |
| NO20022684L NO20022684L (no) | 2002-06-25 |
| NO331464B1 true NO331464B1 (no) | 2012-01-09 |
Family
ID=23814141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022684A NO331464B1 (no) | 1999-12-08 | 2002-06-06 | Antistoff for immunoanalyse for neonicotinyl-insekticider, proteinkonjugat, fremgangsmate for bestemmelse av konsentrasjon, samt et sett. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7148029B2 (fr) |
| EP (1) | EP1235805B1 (fr) |
| JP (1) | JP4980536B2 (fr) |
| KR (1) | KR100752536B1 (fr) |
| CN (1) | CN100379725C (fr) |
| AR (2) | AR026735A1 (fr) |
| AT (1) | ATE343564T1 (fr) |
| AU (1) | AU778677B2 (fr) |
| BR (1) | BR0016265B1 (fr) |
| CA (1) | CA2393084C (fr) |
| CZ (1) | CZ303174B6 (fr) |
| DE (1) | DE60031570T2 (fr) |
| DK (1) | DK1235805T3 (fr) |
| EA (1) | EA005380B1 (fr) |
| ES (1) | ES2272357T3 (fr) |
| HU (1) | HU229490B1 (fr) |
| IL (2) | IL150009A0 (fr) |
| MA (1) | MA25635A1 (fr) |
| MX (1) | MXPA02005514A (fr) |
| NO (1) | NO331464B1 (fr) |
| NZ (1) | NZ519152A (fr) |
| PL (1) | PL205061B1 (fr) |
| PT (1) | PT1235805E (fr) |
| UA (1) | UA76708C2 (fr) |
| WO (1) | WO2001042787A2 (fr) |
| ZA (1) | ZA200204582B (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2433989B (en) | 2004-07-01 | 2009-04-08 | Central Science Lab | Analyte detection system |
| JP2006282547A (ja) * | 2005-03-31 | 2006-10-19 | Horiba Ltd | ニテンピラムのハプテン化合物、抗体、ハイブリドーマ、およびその測定手段、測定用キットまたは測定方法 |
| JP4841856B2 (ja) * | 2005-03-31 | 2011-12-21 | 株式会社堀場製作所 | クロチアニジンおよびジノテフランのハプテン化合物、抗体、ハイブリドーマおよびその測定手段、測定キットまたは測定方法 |
| SI1888641T1 (sl) * | 2005-05-18 | 2012-05-31 | Ablynx Nv | Proteini ki vežejo serum albumin |
| KR100696615B1 (ko) | 2005-10-06 | 2007-03-19 | 충북대학교 산학협력단 | 이미다크로플리드 분석 방법 및 이의 분석 시스템 |
| JP2007187650A (ja) * | 2005-12-16 | 2007-07-26 | Horiba Ltd | 免疫測定法を用いたフィプロニルの測定キット |
| US8323904B2 (en) | 2005-12-16 | 2012-12-04 | Bayer Cropscience Ag | Kit for measurement of termite insecticide active ingredient by immunoassay method |
| CA2641544C (fr) * | 2006-02-10 | 2011-01-11 | Mitsui Chemicals, Inc. | Procede de fabrication de o-methyl-n-nitroisouree |
| CN100402522C (zh) * | 2006-02-13 | 2008-07-16 | 中国农业大学 | 一种净化常山酮的方法及其专用免疫亲和色谱柱 |
| KR100879222B1 (ko) | 2006-05-09 | 2009-01-15 | 재단법인서울대학교산학협력재단 | 제초제 메타미포프 잔류물 검출용 효소면역학적 분석법 |
| KR100876435B1 (ko) | 2007-05-22 | 2008-12-31 | 재단법인서울대학교산학협력재단 | 살충제 비스트리플루론 잔류물의 효소면역학적 분석에이용되는 합텐-단백질 복합체 및 항체 |
| KR100879223B1 (ko) | 2007-05-22 | 2009-01-15 | 재단법인서울대학교산학협력재단 | 살충제 비스트리플루론 잔류물 검출용 효소면역학적 분석법 |
| US9207240B2 (en) * | 2007-11-14 | 2015-12-08 | Arbor Vita Corporation | Method of efficient extraction of protein from cells |
| CN101880325A (zh) * | 2010-06-22 | 2010-11-10 | 南京农业大学 | 一种应用于吡虫啉农药残留检测的单克隆抗体 |
| WO2012151465A1 (fr) | 2011-05-04 | 2012-11-08 | Pop Test, Llc | Dispositif de diagnostic |
| CN102636643A (zh) * | 2012-04-06 | 2012-08-15 | 上海交通大学 | 用于检测噻虫啉的免疫传感器及其制备方法 |
| ES2666000T3 (es) | 2012-08-21 | 2018-04-30 | Janssen Pharmaceutica, N.V. | Anticuerpos para aripiprazol y uso de los mismos |
| WO2014031587A1 (fr) * | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptènes de l'olanzipine |
| US20140057303A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Antibodies to Olanzapine Haptens and Use Thereof |
| EP2888234B1 (fr) * | 2012-08-21 | 2017-12-06 | Janssen Pharmaceutica NV | Haptènes d'aripiprazole et leur utilisation dans des dosages immunologiques |
| CN107253993B (zh) | 2012-08-21 | 2021-10-22 | 詹森药业有限公司 | 奥氮平的抗体及其用途 |
| CN104736567B (zh) | 2012-08-21 | 2019-09-03 | 詹森药业有限公司 | 阿立哌唑半抗原的抗体及其用途 |
| CN102942519B (zh) * | 2012-10-31 | 2014-08-13 | 天津科技大学 | 烯啶虫胺半抗原、人工抗原和抗体及其制备方法与应用 |
| CN104974256B (zh) * | 2015-04-10 | 2018-06-05 | 南京农业大学 | 一种抗噻虫啉单克隆抗体及其用途 |
| CN105037344A (zh) * | 2015-06-16 | 2015-11-11 | 环境保护部南京环境科学研究所 | 一种噻虫啉半抗原的合成方法 |
| CN105087498B (zh) * | 2015-09-07 | 2018-01-09 | 江南大学 | 一株苯噻氰单克隆抗体杂交瘤细胞株及其应用 |
| CN105572376B (zh) * | 2016-03-07 | 2017-07-11 | 中国烟草总公司贵州省公司 | 一种检测农作物中甲基硫菌灵残留的试纸及其应用、制备方法 |
| KR102225307B1 (ko) | 2017-10-19 | 2021-03-11 | 경북대학교 산학협력단 | 왁스 에스테르를 유효성분으로 포함하는 엔도설판 잔류 여부 판단용 또는 엔도설판 독성 확인용 바이오마커 조성물 및 이의 용도 |
| CN109813894A (zh) * | 2017-11-18 | 2019-05-28 | 镇江亿特生物科技发展有限公司 | 一种检测大米中乙虫腈的化学发光免疫检测试剂盒 |
| CN108998422A (zh) * | 2018-08-14 | 2018-12-14 | 江南大学 | 一种分泌噻虫嗪单克隆抗体的杂交瘤细胞株及其应用 |
| CN109061158B (zh) * | 2018-09-21 | 2021-09-03 | 中国烟草总公司郑州烟草研究院 | 一种检测啶虫脒的时间分辨荧光免疫层析试纸条及其制备方法和应用 |
| CN109111394B (zh) * | 2018-09-21 | 2021-09-03 | 中国烟草总公司郑州烟草研究院 | 一种啶虫脒半抗原与抗原的制备方法及应用 |
| CN109917126A (zh) * | 2019-02-27 | 2019-06-21 | 成都市房屋安全事务中心((成都市白蚁防治研究中心)) | 一种检测吡虫啉的试纸条、吡虫啉半抗原的制备方法及检测吡虫啉残留的方法 |
| CN111646959B (zh) * | 2020-05-14 | 2022-07-15 | 广州海关技术中心 | 一种呋虫胺半抗原、胶体金标记呋虫胺单克隆抗体以及呋虫胺胶体金检测装置 |
| CN112111011B (zh) * | 2020-07-28 | 2022-04-19 | 浙江大学 | 一种特异性抗噻虫嗪抗体的可变区序列及其重组全长抗体 |
| CN113009057B (zh) * | 2020-10-22 | 2023-11-07 | 重庆医科大学 | 固相萃取-超高效液相色谱-串联质谱法检测尿液中新烟碱类杀虫剂及代谢产物的方法 |
| CN112595850A (zh) * | 2020-11-18 | 2021-04-02 | 北京勤邦生物技术有限公司 | 一种噻虫胺人工抗原在酶联免疫试剂盒中的应用 |
| CN113281501B (zh) * | 2021-05-12 | 2023-07-07 | 北京勤邦科技股份有限公司 | 一种五氯硝基苯人工抗原在酶联免疫试剂盒中的应用 |
| CN113979994A (zh) * | 2021-12-28 | 2022-01-28 | 信达安检测技术(天津)有限公司 | 一种吡虫啉半抗原、完全抗原及其合成与应用 |
| CN114397441A (zh) * | 2022-01-25 | 2022-04-26 | 中国农业科学院蔬菜花卉研究所 | 一种啶虫脒化学发光免疫分析试剂盒及其制备方法和应用 |
| CN114636768B (zh) * | 2022-03-23 | 2023-11-07 | 广西-东盟食品检验检测中心 | 一种茉莉花中噻虫嗪残留的检测方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5334528A (en) * | 1989-10-30 | 1994-08-02 | The Regents Of The University Of California | Monoclonal antibodies to cyclodiene insecticides and method for detecting the same |
| JPH0580553A (ja) | 1991-09-24 | 1993-04-02 | Mita Ind Co Ltd | 電子写真感光体 |
| TW240163B (en) * | 1992-07-22 | 1995-02-11 | Syngenta Participations Ag | Oxadiazine derivatives |
| GB9304191D0 (en) * | 1993-03-02 | 1993-04-21 | Ciba Geigy Ag | Process for the preparation of aqueous nicotinaldehyde |
| DE4329952C1 (de) * | 1993-09-04 | 1994-08-04 | Draegerwerk Ag | Monoklonale Antikörper zum Nachweis von Pyrethroiden sowie Verfahren zu deren Herstellung |
| US5553209A (en) | 1994-01-28 | 1996-09-03 | Hughes Aircraft Company | Method for automatically displaying map symbols |
| US5849758A (en) * | 1995-05-30 | 1998-12-15 | American Cyanamid Company | Herbicidal 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines |
| EP0854721B1 (fr) * | 1995-08-02 | 2001-10-24 | Smithkline Beecham Corporation | Antagonistes des recepteurs a l'endotheline |
| US5972842A (en) * | 1996-12-12 | 1999-10-26 | American Cyanamid Company | Herbicidal cyanopyridines |
| IL130298A (en) * | 1996-12-19 | 2004-03-28 | Syngenta Participations Ag | Process for preparing thiazole derivatives |
| JP2993902B2 (ja) * | 1997-02-26 | 1999-12-27 | 株式会社環境免疫技術研究所 | トリフルミゾールのハプテン化合物、抗体及び測定方法 |
| JP3188641B2 (ja) * | 1997-03-18 | 2001-07-16 | 株式会社環境免疫技術研究所 | ミクロブタニルのハプテン化合物、抗体及び測定方法 |
| JP3188642B2 (ja) * | 1997-03-19 | 2001-07-16 | 株式会社環境免疫技術研究所 | イマザリルのハプテン化合物、抗体及び測定方法 |
| AU749237B2 (en) * | 1997-10-27 | 2002-06-20 | Isk Americas Incorporated | Substituted benzene compounds, process for their preparation, and herbicidal and defolient compositions containing them |
| US6121202A (en) * | 1997-11-07 | 2000-09-19 | American Cyanamid Company | Thienyloxypyridines and-pyrimidines useful as herbicidal agents |
| DE19831246A1 (de) * | 1998-07-11 | 2000-01-13 | Clariant Gmbh | Verfahren zur Herstellung von Arylpyridinen |
| JP3884586B2 (ja) * | 1998-12-24 | 2007-02-21 | 株式会社堀場製作所 | イミダクロプリドのハプテン化合物、抗体及び測定方法 |
| US6960595B2 (en) * | 2001-03-23 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | 5-6 to 5-7 Heterobicycles as factor Xa inhibitors |
-
2000
- 2000-06-12 UA UA2002075564A patent/UA76708C2/uk unknown
- 2000-12-06 KR KR1020027007294A patent/KR100752536B1/ko active IP Right Grant
- 2000-12-06 JP JP2001544026A patent/JP4980536B2/ja not_active Expired - Fee Related
- 2000-12-06 BR BRPI0016265-5A patent/BR0016265B1/pt not_active IP Right Cessation
- 2000-12-06 CZ CZ20021969A patent/CZ303174B6/cs not_active IP Right Cessation
- 2000-12-06 HU HU0203499A patent/HU229490B1/hu not_active IP Right Cessation
- 2000-12-06 NZ NZ519152A patent/NZ519152A/en not_active IP Right Cessation
- 2000-12-06 EA EA200200620A patent/EA005380B1/ru not_active IP Right Cessation
- 2000-12-06 PL PL355630A patent/PL205061B1/pl unknown
- 2000-12-06 EP EP00989956A patent/EP1235805B1/fr not_active Expired - Lifetime
- 2000-12-06 AR ARP000106458A patent/AR026735A1/es not_active Application Discontinuation
- 2000-12-06 CA CA2393084A patent/CA2393084C/fr not_active Expired - Lifetime
- 2000-12-06 AU AU26721/01A patent/AU778677B2/en not_active Ceased
- 2000-12-06 AT AT00989956T patent/ATE343564T1/de active
- 2000-12-06 CN CNB008177716A patent/CN100379725C/zh not_active Expired - Fee Related
- 2000-12-06 ES ES00989956T patent/ES2272357T3/es not_active Expired - Lifetime
- 2000-12-06 IL IL15000900A patent/IL150009A0/xx active IP Right Grant
- 2000-12-06 PT PT00989956T patent/PT1235805E/pt unknown
- 2000-12-06 US US10/149,512 patent/US7148029B2/en not_active Expired - Lifetime
- 2000-12-06 WO PCT/EP2000/012310 patent/WO2001042787A2/fr active IP Right Grant
- 2000-12-06 DE DE60031570T patent/DE60031570T2/de not_active Expired - Lifetime
- 2000-12-06 MX MXPA02005514A patent/MXPA02005514A/es active IP Right Grant
- 2000-12-06 DK DK00989956T patent/DK1235805T3/da active
-
2002
- 2002-06-03 IL IL150009A patent/IL150009A/en not_active IP Right Cessation
- 2002-06-06 NO NO20022684A patent/NO331464B1/no not_active IP Right Cessation
- 2002-06-07 MA MA26676A patent/MA25635A1/fr unknown
- 2002-06-07 ZA ZA200204582A patent/ZA200204582B/xx unknown
-
2008
- 2008-01-11 AR ARP080100138A patent/AR064873A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO331464B1 (no) | Antistoff for immunoanalyse for neonicotinyl-insekticider, proteinkonjugat, fremgangsmate for bestemmelse av konsentrasjon, samt et sett. | |
| CA2602849C (fr) | Dosage immunologique de doxorubicine | |
| CN109061169B (zh) | 一种检测啶虫脒的酶联免疫试剂盒及其应用 | |
| CN109111394B (zh) | 一种啶虫脒半抗原与抗原的制备方法及应用 | |
| CN109734621B (zh) | 1-萘酚半抗原及其制备方法和应用 | |
| CN109061146B (zh) | 一种检测啶虫脒的试纸条及其制备方法和应用 | |
| CN109053477B (zh) | 一种仲丁灵半抗原与抗原的制备方法及应用 | |
| CN109061158B (zh) | 一种检测啶虫脒的时间分辨荧光免疫层析试纸条及其制备方法和应用 | |
| CN113717255A (zh) | 一种多粘菌素b和粘菌素半抗原、人工抗原及其制备方法与应用 | |
| CN114317450B (zh) | 一株分泌氟苯虫酰胺单克隆抗体杂交瘤细胞株及其应用 | |
| CN114774368B (zh) | 一株分泌抗丙炔氟草胺单克隆抗体的杂交瘤细胞株及其应用 | |
| CN113307776B (zh) | 一种双特异性识别阿苯达唑和多菌灵的抗体制备和应用 | |
| CN118702647A (zh) | 一种灭草松半抗原、抗体、杂交瘤细胞株及其应用 | |
| CN114249705A (zh) | 一种赤霉素半抗原与抗原的制备及其应用 | |
| CN118325845A (zh) | 一株分泌抗环酯草醚单克隆抗体的杂交瘤细胞株及其应用 | |
| CN115418354A (zh) | 一株分泌苯氧威单克隆抗体的杂交瘤细胞株及其应用 | |
| CN116535515A (zh) | 一种抗吡蚜酮的单克隆抗体及其应用 | |
| CN109061170A (zh) | 一种检测二甲戊灵的酶联免疫试剂盒及其应用 | |
| JPH09278800A (ja) | メトプレンに特異的なモノクローナル抗体、それを産生するハイブリドーマ、及びメトプレンの測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |